Added to YB: 2026-01-12
Pitch date: 2026-01-09
LSL.V [bullish]
LSL Pharma Group Inc.
Author Info
Wolf of Oakville takes a magnifying glass to Canadian small cap stocks. Sign up for the newsletter.
Company Info
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally.
Market Cap
CAD 50.9M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.08
P/E
18.51
EV/Sales
2.71
Sector
Personal Care Products
Category
growth
LSL Pharma Group ($LSL.V) FINS Review
LSL.V (new position): Quebec pharma co w/ 7 straight qtrs of 55%+ rev growth, scaling from pre-revenue in 2022 to $27M TTM. 4 acquisitions including recent $5M Juno OTC ($25M 2026 rev est). Potential $60M+ 2026 rev at sub-1x P/S. Risks: high debt load ($24.4M), dilution concerns, & finance costs hindering profitability.
Read full article (7 min)